Physician profile
John Ward Macarthur
NPI 1891957106
$18,424.14
in general payments reported to CMS, 2019-2025
6 companies · $5,169 in 2025
The $5,169 reported for 2025 was more than what 83% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $659 · 2021: $319 · 2022: $1,417 · 2023: $1,546 · 2024: $9,314 · 2025: $5,169.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $3,945.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,083.55 |
| Food and Beverage | $3,945.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $11,622.21 | 2020-2025 | Mitris Resilia Mitral Valve, Inspiris Resilia Aortic Valve, Edwards Intuity Elite Valve System |
| Transmedics, INC. | $4,343.88 | 2024 | Organ Care System |
| Abbott Laboratories | $1,854.56 | 2021-2025 | Mitraclip, Navitor |
| Medtronic, INC. | $265.76 | 2022 | |
| Atricure, INC. | $215.42 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Paragonix Technologies, INC. | $122.31 | 2024 | Baroguard, Sherpapak, Lungguard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Macarthur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.